Bayer celebrates Cardiovascular | Unleashing our collective wisdom for Vericiguat and Finerenone | Nov 23

🚀 Join us for an enlightening Cardiovascular Day at Bayer, where we converge to share valuable insights, explore the latest market trends, and engage in informative sessions tailored to elevate our understanding of innovative technologies and customer interactions. The Vericiguat way. Join us for a Chat: Exploring the Vericiguat Journey and Our Approach for 2024. We're here to share our innovative strategy, answer your questions about what's going on with Vericiguat, and discuss the upcoming milestones our team is working towards. Let's keep it casual and informative! Sharing is caring! Show you care about Finerenone and share your knowledge to accelerate our growth in 2024. We’ll kick start the session with some basics about our brand to then engage you in exercises to enrich our 2024 plans. 🌟 This event is a catalyst for collaboration and knowledge exchange across functions, empowering us to harness synergies and foster cross-functional partnerships to drive impactful results. Embracing the ONE CV spirit is at the core of our agenda – a blend of team-building activities and social interactions that strengthen connections among peers. 🌈 Let's seize this opportunity to unite, learn, and celebrate the Bayer way! 🎉 Text modified by Open AI's ChatGPT Art created by Lena Schermer & Stable Diffusion, modified with Open AI's Dall-E2